Isosorbide Mononitrate and Cilostazol Treatment in Patients With Symptomatic Cerebral Small Vessel Disease: The Lacunar Intervention Trial-2 (LACI-2) Randomized Clinical Trial

Joanna m. Wardlaw, Lisa j. Woodhouse, Iris i. Mhlanga, Katherine Oatey, Anna k. Heye, John Bamford, Vera Cvoro, Fergus n. Doubal, Timothy England, Ahamad Hassan, Alan Montgomery, John t. O’brien, Christine Roffe, Nikola Sprigg, David j. Werring, Philip m. Bath, Colin Baigent, Gary Ford, Jonathan Emberson, Alison MurrayA ross Naylor, Kailash Krishnan, Jesse Dawson, Chris Patterson, German Guzman gutierrez, Stephen Makin, Usman Khan, Laszlo Sztriha, Thomas Booth, Amanathan Kirthivasan, Anwar Ijaz, Kirsty Harkness, Sevasti Ispoglou, Nigel Smyth, Aravinth Sivagnanaratnam, David Cohen, Lakshmanan Sekaran, Dinesh Chadha, Nasar Ahmad, Pratap Rana, Malik Hussain, Nic Weir, Thomas Harrison, Salim Elyas

Research output: Contribution to journal › Article › peer-review

56 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Isosorbide Mononitrate and Cilostazol Treatment in Patients With Symptomatic Cerebral Small Vessel Disease: The Lacunar Intervention Trial-2 (LACI-2) Randomized Clinical Trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science